Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylergometrine
Drug ID BADD_D02417
Description A homolog of ergonovine containing one more CH2 group. (Merck Index, 11th ed)
Indications and Usage For the prevention and control of excessive bleeding following vaginal childbirth
Marketing Status Not Available
ATC Code G02AB01
DrugBank ID DB00353
KEGG ID D08207
MeSH ID D008755
PubChem ID 8226
TTD Drug ID D05AHE
NDC Product Code Not Available
Synonyms Methylergonovine | Methylergometrine | Methylergobasin | Methylergometrin | Methylergonovine Maleate | Methylergometrine Maleate | Methergine | Méthergin | Methergin
Chemical Information
Molecular Formula C20H25N3O2
CAS Registry Number 113-42-8
SMILES CCC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Respiratory disorder22.02.07.0020.010281%Not Available
Restlessness19.11.02.002; 17.02.05.0210.015422%
Rhinitis22.07.03.006; 11.01.13.0040.010281%
Seizure17.12.03.0010.015422%
Tachypnoea22.02.01.0140.015422%Not Available
Vomiting07.01.07.0030.046267%
Gastrointestinal hypermotility07.02.04.0050.010281%Not Available
Decreased appetite14.03.01.005; 08.01.09.0280.010281%
Respiratory tract infection22.07.07.001; 11.01.08.0170.010281%Not Available
Peripheral venous disease24.04.02.0220.010281%Not Available
Posturing19.11.03.008; 17.01.02.0240.010281%Not Available
General physical condition abnormal13.15.01.0400.010281%Not Available
The 2th Page    First    Pre   2    Total 2 Pages